doi: 10.1038/s41467-020-14309-w Ast J, Novak AN, Podewin T, Fine NHF, Jones B, Tomas A, Birke R, Romann K, Mathes B, Eichhorst J, Lehmann M, Linnemann AK, Hodson DJ, Broichhagen J
Intra-day precision (CV) ranged from 0.44.4%, 0.42.9%, and 0.44.8% for low (L), medium (M), and high (H) concentration levels, respectively
All other data, including immunoblots, GSH and AA, were also analysed for statistical significance using a two-tailed unpaired Students t -test unless stated otherwise
Posted on 09 July 2025 Semaglutide enters the market as a weight loss medication In March 2023, the UKs medicines regulator, NICE recommended that specialist weight management services should start offering obese patients weight loss injections containing semaglutide